Comparison Between Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers for Incidence of Lung Cancer: A Retrospective Study

Introduction: Angiotensin-converting enzyme inhibitor (ACEI) and angiotensin II receptor blockers (ARBs) are taken as the first treatment option for hypertensive patients. The various global trials have suggested that ACEIs and ARBs may increase risk of lung cancer; however, the results are contradi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cureus
Main Authors: Kumar, Pardeep, Kumar, Vinod, Murlidhar, Manish, Fatima, Aliya, Jahangir, Maha, Khalid, Dua, Memon, Muhammad Khizar, Memon, Sidra, Kumar, Besham
Formato: Artigo
Idioma:Inglês
Publicado em: Cureus 2021
Assuntos:
Cardiology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8168993/
https://ncbi.nlm.nih.gov/pubmed/34094750
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.14788
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados